In a report released on February 7, Brian Foran from Truist Financial maintained a Buy rating on Huntington Bancshares (HBAN – Research ...
Truist Financial analyst Joon Lee maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s shares closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback